Alyeska Investment Group, L.P. Lucid Diagnostics Inc. Transaction History
Alyeska Investment Group, L.P.
- $29.9 Billion
- Q3 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,383,116 shares of LUCD stock, worth $1.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,383,116
Previous 738,277
87.34%
Holding current value
$1.49 Million
Previous $849,000
64.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LUCD
# of Institutions
85Shares Held
32.9MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.97MShares$5.37 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA4MShares$4.32 Million0.15% of portfolio
-
Abrdn PLC3.46MShares$3.73 Million0.01% of portfolio
-
Two Seas Capital LP Rye, NY3MShares$3.24 Million0.06% of portfolio
-
Awm Investment Company, Inc. New York, NY2.99MShares$3.23 Million0.37% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $41.7M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...